FDA expands approved use of metastatic breast cancer treatment to include male patients
The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine ...
The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine ...
The U.S. Food and Drug Administration said on Monday that it had approved Otsuka Pharmaceutical Co Ltd’s Abilify MyCite, the ...
Welcome to the latest drug price scandal: a rare disease treatment with a list price of more than $700,000 per ...
A consultant studying a mammogram. Photograph: Rui Vieira/PA Sarah Boseley Health editor Thursday 17 November 2016 00.01 GMT View more sharing ...
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.